- Conditions
- Inferior Alveolar Nerve Injuries
- Interventions
- 4% Articaine with 1:200,000 epinephrine, 2% lidocaine with 1:100,000 epinephrine
- Drug
- Lead sponsor
- Cleveland Dental Institute
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 2
- States / cities
- Akron, Ohio • Ashtabula, Ohio
Source: ClinicalTrials.gov public record
Updated Aug 25, 2024 · Synced May 21, 2026, 7:39 PM EDT